Geopolitics & Trade

Benchmark Electronics poaches a key executive from rival Flex, signaling an aggressive push for commercial growth and supply chain resilience under new leadership.

Beyond the headline, Azul's acquisition of Payara signals a major shift, creating a unified open-source alternative to challenge proprietary Java platforms.

A new campaign tackles undiagnosed kidney disease. But is it just public health, or a savvy strategy to reshape a multi-billion dollar market?

Value Added Distributors' purchase of a wire harness maker isn't just a deal; it's a strategic play reshaping the landscape for OEM component suppliers.

Enverus unveils an 'AI operating system' for energy, promising a 10x productivity boost. But what does this mean for the industry's security and future?

Beyond fiber and 5G, a bank's strategic hire in asset-based lending reveals the hidden financial infrastructure powering our connected future.

A regulatory filing reveals a key investor's move as Alkermes' $2.1B bid for Avadel and its blockbuster narcolepsy drug, LUMRYZ, nears its final act.

Kim Thinggaard's return as CEO of Enemærke & Petersen signals a strategic doubling-down on the trust-based partnership model he pioneered.

As federal aid dwindles, a major health system invests in an innovative food network, betting on infrastructure to combat hunger and chronic disease.

With Sir Nick Clegg and AI pioneer Yann LeCun on board, HIRO Capital's new fund is a bold bet on Europe's ability to lead in deep tech innovation.

A $2.4B semiconductor deal seems distant from medicine, but it's forging the AI hardware backbone for the next generation of precision health.

BAE Systems lands a $1.7B deal for its laser-guidance kits, showcasing a disruptive technology that turns dumb rockets into smart weapons for less.

A hedge fund's 2.34% derivatives stake in Alphawave IP suggests a major acquisition by Qualcomm, highlighting a high-stakes battle for key chip IP.

A minor share sale by a US giant in a UK tech firm reveals the subtle art of institutional investing and the power of regulatory transparency.

Cisive's integration with Oracle HCM isn't just a tech update; it's a strategic move to embed compliance and trust directly into hiring workflows.

Bregal Milestone's majority investment in Beyond Now is more than a deal; it’s a bet on how Agentic AI will rewire complex digital supply chains.

Lightbeam's new NCQA prevalidation isn't just a certificate. It's a strategic move reshaping compliance, patient outcomes, and the health tech market.

With a new $2B share buyback and strong dividends, Royal Caribbean isn't just recovering; it's setting a new course for shareholder value and growth.

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?

Chatham Lodging Trust's dividend hike isn't just a payout. It’s a strategic signal about the future of upscale travel and savvy hotel investment.